Sonic Healthcare – Valuation Review

Sonic Healthcare is under Algo Engine sell conditions, however, we take the time to look at the financial outlook of the business, following yesterday’s FY19 result.

FY19 sales revenue was up 11.6% and EBIT growth increased by 10%.

You're not a member!  Trial today!

Excluding any FX benefit, we expect Sonic to grow FY20 EBITDA at 6 – 8%, which will support a forward yield of 3.2%.

The stock is trading on FY20 PE of 23x earnings and we will look to buy SHL on the next Algo Engine buy signal.

 

 

 

 

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2020 Investor Signals